RE: Risk?3 Oct 2020 17:53
I'm definitely in the glee club. However, if you are risk adverse, you have no business investing in any UK stock right now, much less the AIM market. Better to liquidate and wait until you find out what the disaster capitalists invest in next year. It really is too risky, with the Β£ climbing back to $1.29 with simple market manipulation.
As for Scancell, there is little doubt of the efficacy of their product line. The only risk involved is the realisation of its value.
I don't consider it a technology push scenario. Rather it is based on user demand. For example, skin cancers account for more than 9% of all cancers in sunny states like Florida, and melanoma has no current cure (and yes, I've lost a relative to it). There is similar demand for their other product lines.
As for a covid vaccine, over 34% of Americans are over 50, and in the UK, almost 12m aged 65 and older. About 349m people around the globe are immunocompromised (obviously there is some overlap). There will be a market for Scancell's vaccine provided it can meet the quality control standards set by regulators. On that note, I'm not sure if the WHO is sticking with their 95% efficacy minimum in the light of the FDA putting the bar at 50%.
#DYOR and remember, there is now enough pent up demand for shares should they take a dip. I doubt we'll be seeing the placing price again. If we do, I'll be buying a million or more.